BackgroundCheck.run
Search For

Paul C Mclean, 69Brookline, MA

Known as:
Mclean C Paul
Related to:
Lynn H Winkler 66

Paul Mclean Phones & Addresses

Brookline, MA   

Roseville, MN   

Allston, MA   

Glendale, CA   

South Pasadena, CA   

Los Angeles, CA   

Work

Company: Cape mathematics Jun 2011 Position: Mathematics tutor

Education

School / High School: University of Technology Jamaica 2007 Specialities: BBA in Production & Operations Management & Finance & Banking

Skills

Painting • Carpentry • Roofing • Inventory Management • Construction Supervision
Get Report
Control this profile

Mentions for Paul C Mclean

Paul Mclean resumes & CV records

Resumes

Paul Mclean Photo 46

Vice President Strategy

Location:
45420 Burgundy Dr, Macomb, MI 48044
Industry:
Medical Devices
Work:
Cardiva Medical
Vice President Strategy Btg
Vice President Upstream Marketing Prospex Medical Apr 2012 - Sep 2018
Vice President Business Development Clarvista Medical Nov 2012 - Dec 2017
President and Chief Executive Officer Boston Scientific 1991 - 2012
Vice President Sales Operations and Strategy Boston Scientific 1991 - 2006
Sales and Marketing
Education:
University of Minnesota - Carlson School of Management 1989 - 1991
Master of Business Administration, Masters, Operations Management Michigan State University 1982 - 1986
Bachelors, Bachelor of Science, Electrical Engineering Waverly High School
Paul Mclean Photo 47

Social Media Writer And Editor

Location:
Brookline, MA
Industry:
Higher Education
Work:
Harvard Medical School Center For Bioethics
Social Media Writer and Editor Harvard Medical School Center For Bioethics
Writing Support The Hastings Center Nov 1, 2015 - Mar 2017
Social Media Marketing Consultant Patient-Centered Outcomes Research Institute ( Pcori ) Nov 1, 2015 - Mar 2017
Co-Investigator Center For Bioethics Harvard Medical School Sep 2014 - Aug 2015
Fellow In Medical Ethics Boston Children's Hospital Sep 2014 - Aug 2015
Ethics Associate Harvard Catalyst Sep 2014 - Aug 2015
Member, Research Subject Advocacy Board Harvard Community Ethics Committee Sep 2014 - Aug 2015
Member, Social Network Coordinator and Blogger Boston Herald 1994 - 2001
Assistant Managing Editor For Arts and Entertainment Variety 1992 - 1994
Editor
Education:
California State University, Los Angeles 1975 - 1978
Bachelors, Bachelor of Arts, Journalism Pasadena City College 1973 - 1975
Associates, Associate of Arts Harvard Medical School
Skills:
Nonprofits, Editing, Medical Ethics, Public Speaking, Healthcare, Bioethics, Social Media, Blogging, Ethics, Microsoft Office
Paul Mclean Photo 48

Paul Mclean

Paul Mclean Photo 49

Paul Mclean

Location:
United States
Paul Mclean Photo 50

Paul Mclean

Location:
United States
Paul Mclean Photo 51

Paul Mclean

Location:
United States
Paul Mclean Photo 52

Paul Mclean

Work:
CAPE Mathematics Jun 2011 to 2000
Mathematics tutor NPG Insurance Brokers Co. Ltd Jan 2010 to Jun 2010 Ministry of National Security (CSJP) Jan 2008 to Jun 2008
Supervisor Jamaica Police Academy Jun 2007 to Aug 2007
A member Atlas Protection limited 2002 to 2006
Security Officer Construction Developers Associates 1996 to 2001
Assistant Site Manager Purchasing 1992 to 1996
Officer Construction Developers Associates 1990 to 1992
Accounts Clerk Construction Developers Associates 1988 to 1990
Office Clerk
Education:
University of Technology Jamaica 2007 to 2012
BBA in Production & Operations Management & Finance & Banking St Georges Extension School 1987 to 1990 Calabar High School 1982 to 1987
Skills:
Painting, Carpentry, Roofing, Inventory Management, Construction Supervision

Publications & IP owners

Us Patents

Methods For Treating Diabetes

US Patent:
2006006, Mar 23, 2006
Filed:
May 27, 2005
Appl. No.:
11/140508
Inventors:
Michael Jesson - Hopedale MA, US
Paul McLean - Cambridge MA, US
Glenn Miller - Merrimac MA, US
Barry Jones - Cambridge MA, US
Assignee:
Point Therapeutics, Inc. - Boston MA
International Classification:
A61K 38/04
A61K 31/69
US Classification:
514019000, 514064000
Abstract:
The invention relates to compositions of Glu-boroPro and methods of use thereof in the prevention or management of type 2 diabetes.

Methods And Compositions For Treating Glucose-Associated Conditions, Metabolic Syndrome, Dyslipidemias And Other Conditions

US Patent:
2006009, May 4, 2006
Filed:
Sep 21, 2005
Appl. No.:
11/233532
Inventors:
Nazneen Aziz - Lexington MA, US
Michael Jesson - Hopedale MA, US
Paul McLean - Cambridge MA, US
Glenn Miller - Merrimac MA, US
Barry Jones - Cambridge MA, US
Assignee:
Point Therapeutics, Inc. - Boston MA
International Classification:
A61K 31/69
US Classification:
514064000
Abstract:
The invention relates, in part, to of Glu-boroPro containing compounds and methods of use thereof in the prevention or management of conditions that are associated with impaired glucose tolerance such as diabetes. The invention also relates to compositions of Glu-boroPro containing compounds and methods of use thereof in the prevention or management of conditions such as metabolic syndrome, dyslipidemias, inflammation, cardiovascular disorders such as hypertension and atherosclerosis, and to reduce body weight or prevent weight gain. The compounds of the invention are also useful in lowering levels of triglycerides, free fatty acids, C-reactive protein (CRP), HbAC, total glycosylated hemoglobin (TGHb), in increasing insulin sensitivity index and in stimulating insulin release.

Methods For Treating Diabetes

US Patent:
2007007, Mar 29, 2007
Filed:
Sep 15, 2006
Appl. No.:
11/522105
Inventors:
Michael Jesson - Hopedale MA, US
Paul McLean - Cambridge MA, US
Glenn Miller - Merrimac MA, US
Barry Jones - Cambridge MA, US
Assignee:
Point Therapeutics, Inc. - Boston MA
International Classification:
A61K 31/69
US Classification:
514064000
Abstract:
The invention relates to compositions of Glu-boroPro and methods of use thereof in the prevention or management of type 2 diabetes.

Olfactory Modifying Devices And Related Methods

US Patent:
2013017, Jul 11, 2013
Filed:
Jan 9, 2013
Appl. No.:
13/737734
Inventors:
Robert E. Atkinson - White Bear Lake MN, US
Jason Galdonik - Minneapolis MN, US
Paul McLean - North Oaks MN, US
Assignee:
Prospex Medical III - New Brighton MN
International Classification:
A62B 23/06
US Classification:
12820611
Abstract:
Olfactory devices and methods for partially or completely blocking, masking or otherwise reducing olfactory input to mitigate adverse responses thereto. In one embodiment, a method of treating a patient with an olfactory-triggered condition may include diagnosing the patient's olfactory-triggered condition. In response to the diagnosis, the method may further include placing an olfactory device over an olfactory area in a nasal cavity of the patient to mitigate the olfactory-triggered condition.

Modular Intraocular Lens Designs And Methods

US Patent:
2013019, Jul 25, 2013
Filed:
Jan 23, 2013
Appl. No.:
13/748207
Inventors:
Malik Y. Kahook - Denver CO, US
Naresh Mandava - Denver CO, US
Paul McLean - North Oaks MN, US
Robert E. Atkinson - White Bear Lake MN, US
International Classification:
A61F 2/16
US Classification:
623 641, 623 638
Abstract:
A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.

Modular Intraocular Lens Designs And Methods

US Patent:
2013031, Nov 21, 2013
Filed:
Jul 9, 2013
Appl. No.:
13/937761
Inventors:
Malik Y. Kahook - Denver CO, US
Naresh Mandava - Denver CO, US
Paul McLean - North Oaks MN, US
Robert E. Atkinson - White Bear Lake MN, US
International Classification:
A61F 2/16
US Classification:
623 634
Abstract:
A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.

Devices And Methods To Reduce Myocardial Reperfusion Injury

US Patent:
2014002, Jan 23, 2014
Filed:
Jul 16, 2013
Appl. No.:
13/943605
Inventors:
Jason Galdonik - Minneapolis MN, US
Peter Keith - Lanesboro MN, US
Paul McLean - North Oaks MN, US
Assignee:
Prospex Medical III - New Brighton MN
International Classification:
A61F 7/12
US Classification:
607105
Abstract:
Devices and methods that mitigate reperfusion injury (RI) in a clinically practical manner so as to avoid significantly increasing time to reperfusion. In general, these systems and methods involve an antegrade approach to deliver a fluid to the myocardium at risk of RI before, during and after reperfusion is established by a percutaneous coronary intervention such as aspiration and stenting.

Modular Intraocular Lens Designs And Methods

US Patent:
2014005, Feb 20, 2014
Filed:
Aug 16, 2013
Appl. No.:
13/969115
Inventors:
Glenn SUSSMAN - Laguna Niguel CA, US
Paul McLEAN - North Oaks MN, US
Robert E. ATKINSON - Lake Elmo MN, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF COLORADO AND CLARVISTA MEDICAL, INC. a body corporate - Denver CO
CLARVISTA MEDICAL, INC. - Aliso Viejo CA
International Classification:
A61F 2/16
US Classification:
623 641
Abstract:
A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.

Isbn (Books And Publications)

The Art Of The Network: Strategic Interaction And Patronage In Renaissance Florence

Author:
Paul D. Mclean
ISBN #:
0822341174

Possible Relatives

Cynthia J Mclean  David J Mclean  Daniel M Mclean  Danielle Mclean  Dennis R Mclean  Diane R Mclean  Doyle G Mclean  Paul M Johnson  Paul Stamps  Paul B Stanaway 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.